Skip to main content
Premium Trial:

Request an Annual Quote

Tripos Discovery Informatics Names New CEO

NEW YORK (GenomeWeb News) – Tripos Discovery Informatics has tapped Jim Hopkins to be CEO of the newly private company, which was purchased last week by Vector Capital for $26.2 million.
 
Hopkins most recently was CEO of the software company Micrografx, now owned by Corel. He is experienced in IPOs, secondary offerings, and in strategic sales and acquisitions, the company said. 
 
Hopkins said he is “excited to lead this organization as an independent company, refocused and poised for profitable growth.”
 
Tripos said it plans to focus on innovating its core technologies, specifically its SYBYL suite, which supports drug-discovery workflows.
The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.